Research Library

Ketamine Research by Condition

Different conditions have different evidence bases. Here's where each one stands.

Written by: Ira ZootMedically reviewed by: Ketalux Clinical Review PanelLast updated: June 6, 2026Evidence: Aggregated published research

Quick answer

Which conditions have the strongest ketamine evidence?

Treatment-resistant depression has the largest evidence base, including the FDA-approved esketamine indication. Suicidal ideation has multiple positive trials. PTSD, anxiety, OCD, and chronic pain have meaningful but smaller evidence bases. Bipolar depression is studied with caution.

Browse by condition

Depression

Largest evidence base; rapid onset; durable with maintenance.

Treatment-resistant depression

FDA-approved esketamine indication; foundational evidence.

Anxiety

Generalized and social anxiety; growing evidence base.

PTSD

Multiple positive trials; integration is critical.

OCD

Smaller evidence base; rapid acute effects in some patients.

Chronic pain

Used for CRPS, neuropathic pain, and other syndromes.

Bipolar depression

Treated with caution; mood-stabilizer coordination essential.

Suicidal ideation

Rapid reduction; bridge to ongoing care.

Educational content only. Not medical advice. Discuss any treatment decisions with a qualified clinician.

About the author

Ira Zoot

Independent publisher and editor of Ketalux, based in Chicago, Illinois. Ira commissions, edits, and reviews every article on the site and believes ketamine therapy — used responsibly — offers real hope for people living with depression, anxiety, PTSD, and chronic pain. Contact: ira@idigits.com.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.